Pilot Testing, Implementation, and Evaluation of the Cervical, Breast and Colorectal Cancer Clinical Decision Support Tools

Key facts

Copied from the official Grants.gov record. Last verified October 29, 2026.

Program name

Pilot Testing, Implementation, and Evaluation of the Cervical, Breast and Colorectal Cancer Clinical Decision Support Tools

Issuing agency

Centers for Disease Control and Prevention - ERA (Department of Health and Human Services)

Opportunity number

RFA-DP-27-036

Funding type

Cooperative Agreement

Funding purpose

Health

Status

Forecasted

Application deadline

Forecasted · estimated close March 23, 2027 (agency estimate)Agency note: Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Agency estimates

Estimated posting: January 21, 2027. Estimated award date: August 30, 2027. Estimates can change.

Published award range

Not published by the agency

Estimated total program funding

$7,250,000

Expected number of awards

2

Cost sharing or match required

No

Eligible applicants (official categories)

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities/Indian housing authorities
• Native American tribal organizations (other than Federally recognized tribal governments)
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Private institutions of higher education
• For profit organizations other than small businesses
• Small businesses
• Others (see Additional Information on Eligibility)
• Unrestricted (open to any type of entity, subject to any clarification in Additional Information on Eligibility)

Relevant to

Businesses and NonprofitsHow we determined this: Grants.gov lists eligibility as Unrestricted. Grants.gov eligibility includes small businesses or for-profit organizations. Grants.gov eligibility includes nonprofit organizations.

Geographic restrictions

None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.

Assistance Listing (CFDA)

93.945

Official source

View on Grants.gov ↗

Application URL

www.grants.gov/search-results-detail/363309 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.

Source identifier

Grants.gov opportunity ID 363309 · Funding opportunity number RFA-DP-27-036

Posted

July 24, 2026 · Source last updated July 24, 2026

Last verified

October 29, 2026 (against Grants.gov)

Data completeness

92% of key fields published by the sourceNot published: published funding range.

Record confidence

mediumforecast — dates and amounts are agency estimates.

Eligibility details (from the agency)

See Section III. Eligibility Information.

Description (from the official listing)

The Centers for Disease Control and Prevention's (CDC) National Center for Chronic Disease Prevention and Health Promotion is advancing the development of clinical decision support (CDS) tools designed to facilitate evidence-based cancer screening and management at the point of care. These CDS tools integrate up-to-date, computable guidelines into electronic health records systems to support clinicians in real-time clinical decision-making. The CDC has previously developed computer algorithms for cervical, breast, and colorectal cancers.This NOFO has two components:Component A. Cervical Cancer Clinical Decision Support (CDS) tool: This component focuses on the system-wide implementation and evaluation of a publicly available cervical cancer CDS tool within a large health system. The primary objective is to enhance guideline-concordant screening and ensure timely follow-up and management after abnormal results. Applicants are expected to rigorously assess both the implementation processes and the efficacy of the tool in improving cervical cancer screening and management. Component B. Breast and Colorectal Cancer CDS tools: This component aims to pilot test publicly available, interoperable CDS tools for breast and colorectal cancer screening. The scope includes technical integration of these tools into real-world electronic health record (EHR) systems within a large health system, comprehensive documentation of the implementation process, and empirical evaluation to assess the accuracy and impact of the tools.

Agency contact

Celeste Sanders, PhD
researchnofo@cdc.gov